But wheres the Money?This is APHA's second facility receiving EU GMP certification. And the first certification helped the bottom line how? Sure, they are expanding globally, clearing regulatory hurdles and maybe, just maybe, this sets up the company for future growth and profit. Still, a near 8% price bump today b/c they received certification? Makes no sense, other than to attribute the price increase to hype. It's not like they reported stellar financial results this month. And they do currently sport $733,713 in long term liabilities. Don't get me wrong; I'm all for the company succeeding. But their future success is just as uncertain today as it was when they reported on Jan 14.